MBX
MBX Biosciences, Inc. Common Stock
NASDAQ · USHealthcareBiotechnology
$60.14-4.42%
Price as of Jul 20, 2026
MBX growth
MBX Biosciences, Inc. Common Stock growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- —
- EBITDA
- -10.0%
- EBIT
- -21.4%
- EPS
- +0.0%
- Free cash flow
- -18.6%
- Operating cash flow
- -16.2%
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- -79.7%
Three-year CAGR
- Revenue
- —
- EBITDA
- -40.6%
- EBIT
- -43.8%
- Net income
- -40.5%
- EPS
- -28.6%
- Free cash flow
- -47.4%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.